FDA Panel Backs COVID-19 Boosters Only for Elderly, Those at High-Risk

September 17, 2021 by Dan McCue
FDA Panel Backs COVID-19 Boosters Only for Elderly, Those at High-Risk
Hollie Maloney, a pharmacy technician, loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. (AP Photo/Robert F. Bukaty, File)

WASHINGTON – A Food and Drug Administration advisory panel voted unanimously Friday to recommend emergency use authorization of a booster dose of Pfizer-BioNTech COVID-19 vaccine six months after full vaccination in people 65 and older and those at high risk of severe Covid-19.

But the same panel — the FDA’s Vaccines and Related Biological Products Advisory Committee — rejected booster doses of the vaccine for everyone over the age of 16.

The decision capped a weeks-long debate among federal and independent scientists about whether the evidence supported a booster shot program that the Biden administration had planned to roll out next week.

Though the panel’s vote is not binding, the FDA usually follows the recommendations of its advisory committee. 

Throughout Friday’s hearing the main points of contention appeared to be whether there was clear evidence the booster shots would provide a benefit to younger people, and whether there was sufficient data to suggest that a broad launch of a booster shot program would be safe.

Much of the concern centered on relatively rare instances of heart inflammation reported in recipients of the Pfizer-BioNTech and Moderna shots, which both rely on mRNA technology.

Representatives of Pfizer told the panel that maintaining high vaccine effectiveness is integral to containing the pandemic, and it argued that administering boosters is the only way to get and stay ahead of the coronavirus.

The company reps also said the effectiveness of its vaccine wanes over time.

Pointing to data from Israel, the Pfizer team said booster performance in people over 60 has already been largely proven, and noted that the country has expanded its vaccine campaign to include boosters for people over 30. 

In a separate presentation, Israeli scientists suggested that their country would have exceeded hospital capacity over the summer had it not begun giving boosters.

But Sara Oliver, a doctor with Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases, said while the vaccines’ efficacy against COVID infections and mild illness has dropped over time, it nevertheless remains high against severe disease and hospitalization.

While all this was going on, the CDC published a report that showed all three of the COVID-19 vaccines available in the United States provide protection against hospitalization.

In addition to Pfizer-BioNTech, the other vaccine makers are Moderna and Johnson & Johnson.

The agency’s study, published in its Morbidity and Mortality Weekly Report, included information on more than 3,600 adults hospitalized at 21 U.S. facilities from March to August.

In related news, the White House announced Friday afternoon that President Biden will convene a virtual COVID Summit on the margins of the UN General Assembly.

“This meeting is about expanding and enhancing our shared efforts to defeat COVID-19, building out from previous gatherings of world leaders and ministers in forums like the G7, G20, and Act Accelerator to rally civil society, NGOs, philanthropists, and industry along with world leaders and align on a common vision for defeating COVID-19 together,” said White House spokeswoman Jen Psaki.

The White House said Biden will be asking participants to commit to of a higher level of ambition across four themes:

  • Vaccinate the World by enhancing equitable access to vaccines and getting shots in arms.
  • Save Lives Now by solving the oxygen crisis, and making tests, therapeutics and PPE more available.
  • Build Back Better by establishing a sustainable health security financing mechanism, and global leadership for emerging threats.
  • Calling the World to Account by aligning around targets, tracking progress, and supporting one another in fulfilling our commitments.

“We will have more to share on the COVID Summit in the coming days,” Psaki said.

A+
a-
  • COVID-19
  • FDA
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top